Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VN-100 randomized double-blind comparative study in healthy adult Japanese volunteers
jRCT2080222050Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2013
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VN-100 in influenza (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Immunogenicity of VN-100 compared with subcutaneous influenza HA vaccine and Safety and tolerability of VN-100. Started Mar 2013; status: completed.
02
Drugs
VN-100
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222050.